Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Phospholipid Scramblase 1/PLSCR1 Antibody, Novus Biologicals™
SDP

Rabbit Polyclonal Antibody

$206.00 - $487.50

Specifications

Antigen Phospholipid Scramblase 1/PLSCR1
Classification Polyclonal
Conjugate Unconjugated
Host Species Rabbit
Regulatory Status RUO
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NBP15781620
SDP
View Documents
Novus Biologicals
NBP15781620UL
20 μL
Each for $206.00
Only null left
Add to Cart
 
NBP157816
SDP
View Documents
Novus Biologicals
NBP157816
100 μL
Each for $487.50
Only null left
Add to Cart
 
Description

Description

Phospholipid Scramblase 1/PLSCR1 Polyclonal specifically detects Phospholipid Scramblase 1/PLSCR1 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin.
Specifications

Specifications

Phospholipid Scramblase 1/PLSCR1
Unconjugated
RUO
O15162
5359
Synthetic peptides corresponding to PLSCR1(phospholipid scramblase 1) Antibody(against the N terminal of PLSCR1. Peptide sequence MDKQNSQMNASHPETNLPVGYPPQYPPTAFQGPPGYSGYPGPQVSYPPPP.
Primary
Polyclonal
Rabbit
Human
Erythrocyte phospholipid scramblase, MmTRA1b, MMTRA1BCa(2+)-dependent phospholipid scramblase 1, phospholipid scramblase 1, PL scramblase 1
PLSCR1
IgG
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.